BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Covalon Announces Issuance of Stock Options

  Covalon Technologies Ltd., an advanced medical technologies company, today announced the issuance of 60,000 stock options to financial advisors of the Company.

  October 27, 2017

   · 

  2 min read
• Chi-Med Announces the Full Exercise of Underwriters’ Over-allotment Option

  The underwriters have elected to purchase an additional 1,483,018 ADSs at the Offering price of US$26.50 per ADS.

  October 27, 2017

   · 

  6 min read
• Genetown

  Biogen and Ionis Win Prestigious Prix Galien Award for SPINRAZA As Best Biotechnology Product

  The Prix Galien USA Award recognizes extraordinary achievement in scientific innovation that improves the state of human health.

  October 27, 2017

   · 

  8 min read
• Business

  Allergan Board of Directors Announces Fourth Quarter 2017 Cash Dividend and Increases Quarterly Cash Dividend for 2018

  Allergan today announced the record and payment dates for a cash dividend of $0.70 per ordinary share for the fourth quarter of 2017.

  October 27, 2017

   · 

  3 min read
• 

  Deals

  Activist Investors Break Up Clariant-Huntsman’s $20B Merger Deal

  The decision was unanimously approved by the Boards of Directors of Clariant and Huntsman.

  October 27, 2017

   · 

  3 min read
• Business

  ASPiRA Labs Lands Strategic Managed Care Coverage and Medicaid Licensure for OVA1

  ASPiRA LABS today announced it has entered into agreements with JVHL, QCA Health Plan of Arkansas, Louisiana State Medicaid program, and Arizona State Medicaid Program to provide coverage for its in vitro diagnostic test, OVA1.

  October 27, 2017

   · 

  3 min read
• Deals

  Medical Company Mergenet Solutions Announces Acquisition of Innomed/Respcare by Salter Labs

  Mergenet Solutions announces the acquisition of Innomed Technologies and Respcare by Illinois based Salter Labs.

  October 27, 2017

   · 

  2 min read
• Business

  Navidea Signs Letter of Intent to Sublicense NAV4694 Worldwide Development Rights

  Cerveau, and/or their fully controlled subsidiary, will act as a designated party for the rights resulting from the relationship between Navidea and Beijing Sinotau Medical Research Co., Ltd. (Sinotau), a subsidiary of Sinotau Pharmaceutical Group.

  October 27, 2017

   · 

  3 min read
• Biotech Bay

  Eiger BioPharma Announces Pricing of Public Offering of Common Stock

  Eiger BioPharma today announced the pricing of its underwritten public offering of 1,854,749 shares of its common stock at a price of $10.00 per share, before underwriting discounts and commissions.

  October 27, 2017

   · 

  3 min read
• Pharm Country

  Efficacy and Safety Results from First Phase III Trial of Oral Ozanimod (SUNBEAM) Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 - 7th Joint ECTRIMS - ACTRIMS Meeting

  The SUNBEAM study evaluated two doses (1 mg and 0.5 mg) of oral ozanimod in 1,346 patients with RMS in 20 countries treated for at least one year.

  October 27, 2017

   · 

  8 min read